Jamie Dimon Signals JPMorgan Could Pursue 20 Billion Acquisition Trump Calls for Totally Independent New Fed Chair Amid Pressure on Predecessor Rupee Opens 35 Paise Higher at 9534 Against US Dollar Amid Improved Risk Sentiment and RBI Support Qualcomm Stock Surge Highlights Investor Optimism Over AI Device Boom Nvidia Stock at Critical Juncture Key Technical Level Could Determine Next Move Microsofts Trusted Technology Chief Discusses Responsible AI Development Approach Ivanhoe Electric Inc Q1 2026 Earnings Deep EPS Miss Amidst PreRevenue Exploration Phase Burlington Stores BURL Q1 2026 Earnings EPS Beat Lifts Stock as OffPrice Model Proves Resilient ARVN Q1 2026 Earnings EPS Beats Expectations as Pipeline Advances Without Revenue SUPV Q1 2026 Earnings Stellar Earnings Surprise as EPS Beats Estimates by Wide Margin FCX Q1 2026 Earnings Copper Producer Beats EPS Estimates by Wide Margin Amid Operational Gains MPT Q1 2026 Earnings EPS Surges Past Estimates with 65 Surprise POWWP Preferred Shares Slip 125 as Cumulative Dividend Yield Attracts Steady Demand Haemonetics HAE Slips Modestly as Stock Tests Support Near 63 Marygold Companies MGLD Edges Lower Amid Light Trading Key Support in Focus eBay EBAY Gains 16 as Price Approaches Key Resistance Level Fifth Era Acquisition Corp I Rights FERAR Holds at 030 as Support and Resistance Converge Bank of America Forecasts 10x Productivity Boost from AI as Implementation Gap Narrows Irans Shift in Hormuz Standoff Implications for Global Oil Markets Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers Meta Cloud Business Definitely on the Table Zuckerberg Signals Amid Data Center Expansion Apollo Global Management and Blackstone Reportedly Working on 36 Billion Debt Deal for AI Firm Anthropic Woodfield Ships Indias First LNG Marine Loading Arm from Mumbai Facility White House and China Tout Progress on Soybeans Rare Earths After TrumpXi Summit While Tariff Cuts Remain in Focus InnovAge Q1 2026 Earnings Deep EPS Miss Sends Shares Lower Vistagen Therapeutics VTGN Approaches Key Support After Marginal Decline